Updates in Intestinal Failure Management
Open Access
- 28 April 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3031
Abstract
Short bowel syndrome (SBS) is a malabsorptive condition resulting from reduced functional small intestinal length. SBS is closely related to intestinal failure (IF), defined as the reduction of functional intestinal mass below that which can sustain life, resulting in parenteral nutrition (PN) support for 60 days or greater within a consecutive 74-day period. IF frequently results from intestinal resection necessitated by such diseases as necrotizing enterocolitis in children and Crohn’s disease in adults. Clinical manifestations of IF may include diarrhea, growth failure, bacterial overgrowth, and vitamin deficiencies. Nutritional rehabilitation is the cornerstone of IF management. Surgical interventions are aimed at preserving intestinal length and restoring continuity. Medical management involves individualized enteral and parenteral nutrition therapy, GLP-2 agonists (e.g., teduglutide) that promote mucosal growth, and drugs for symptom management such as antidiarrheals. Experimental therapies such as the use of devices to induce intestinal growth through distraction enterogenesis are under development for the treatment of IF. An interdisciplinary approach involving surgeons, gastroenterologists, dietitians, nurses, and social workers is crucial in the management of these complex patients. Ultimately, a combination of nutritional, medical, and surgical management may be necessary to improve clinical outcomes in patients with IF.Keywords
This publication has 81 references indexed in Scilit:
- Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high‐risk pediatric patients with intestinal failure: A retrospective cohort studyJournal of Parenteral and Enteral Nutrition, 2024
- Predictors of 1‐year enteral autonomy in children with intestinal failure: A descriptive retrospective cohort studyJournal of Parenteral and Enteral Nutrition, 2023
- Ethanol lock therapy increases mechanical catheter complications in a pediatric intestinal failure population: A retrospective cohort studyJournal of Parenteral and Enteral Nutrition, 2023
- Impact of intestinal failure and parenteral support on adult patients with short‐bowel syndrome: A multinational, noninterventional, cross‐sectional surveyJournal of Parenteral and Enteral Nutrition, 2022
- ASPEN definitions in pediatric intestinal failureJournal of Parenteral and Enteral Nutrition, 2021
- Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trialJournal of Parenteral and Enteral Nutrition, 2021
- High Parenteral Support Volume Is Associated With Reduced Quality of Life Determined by the Short‐Bowel Syndrome Quality of Life Scale in Nonmalignant Intestinal Failure PatientsJournal of Parenteral and Enteral Nutrition, 2020
- Evaluation of SMOFlipid in Pediatric Intestinal‐Failure Patients and Its Effects on Essential Fatty Acid LevelsJournal of Parenteral and Enteral Nutrition, 2020
- Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III StudyJournal of Parenteral and Enteral Nutrition, 2019
- Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unitCochrane Database of Systematic Reviews, 2018